Core Insights - U.S. Physical Therapy, Inc. presented at the Barclays 28th Annual Global Healthcare Conference on March 11, 2026, highlighting its role as a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services [1][1][1] Company Overview - Founded in 1990, U.S. Physical Therapy operates 783 outpatient physical therapy clinics across 44 states, offering preventative and post-operative care for orthopedic and sports-related injuries, as well as treatment for neurological injuries and rehabilitation for injured workers [1][1][1] - The company also provides industrial injury prevention services, including onsite injury prevention, rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments [1][1][1] Financial Highlights - For the year ended December 31, 2025, U.S. Physical Therapy reported an Adjusted EBITDA of $95.0 million, indicating a strong financial performance compared to the previous year [1][1][1] - The company announced the acquisition of an industrial injury prevention business for approximately $15.1 million, which currently generates about $7.0 million in annual revenues [1][1][1]

Core Viewpoint - U.S. Physical Therapy, Inc. will report its financial results for Q4 and the full year of 2025 on February 25, 2026, after market close, with a conference call scheduled for the following morning [1] Financial Reporting - The financial results will cover the fourth quarter and the entire year ending December 31, 2025 [1] - The announcement of the results will occur after the stock market closes on February 25, 2026 [1] - A conference call to discuss the results will take place on February 26, 2026 [1]

Core Insights - U.S. Physical Therapy, Inc. is a national operator of outpatient physical therapy clinics and provides industrial injury prevention services [1] - The company was founded in 1990 and currently owns and/or manages 780 outpatient physical therapy clinics [1] Company Presentation - Chris Reading, the Chief Executive Officer, presented at the J.P. Morgan 2026 Healthcare Conference on January 14, 2026 [1]